ArticleThe Korean journal of internal medicine2020

Clinical outcome and predictive factors for docetaxel and epirubicin neoadjuvant chemotherapy of locally advanced breast cancer.

Hye Sung Won et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.